drugset / Trial / NCT01456689
A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of this dose escalation study is to estimate the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) of LGH447 as a single agent when administered orally once daily to adult patients with Multiple Myeloma (MM).
Timeline
- Start
- 2012-04-25
- Primary completion
- 2019-06-05
- Completion
- 2019-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LGH447 | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | — |